Trust the MS Center at Holy Name Medical Center for integrated, comprehensive care that includes accurate diagnostics, full access to all hospital services and emerging therapies through clinical trials.
Since 1985, the MS Center at Holy Name Medical Center in Teaneck, New Jersey, has served as a regional leader in MS care, providing unparalleled, holistic care to patients of all ages living with multiple sclerosis. Approximately 1,800 patients from the greater New York metropolitan region visit the MS Center for its clinical excellence, personalized patient care and innovative clinical research. We take a holistic approach to healing and have integrated our MS services with others throughout the hospital so that patients feel completely supported and cared for from diagnosis through treatment and maintenance. The MS Center is one of a select few multiple sclerosis centers in the region—and the only facility in Bergen County, New Jersey—to be affiliated with the New Jersey Metro Chapter of the National Multiple Sclerosis Society.
Our highly experienced, multidisciplinary team of neurologists and experts provide a full spectrum of services tailored to the unique medical and emotional needs of MS patients. These services include advanced diagnostics, novel treatment strategies, and psychosocial, rehabilitative and supportive care. Receiving your care at the MS Center also means having full access to Holy Name Medical Center's recognized doctors and a broad array of specialties, including preventive care, urology, ophthalmology, radiology, cardiology, gastroenterology, and women's health as well as clinical research studies and neuropsychological evaluation.
Holy Name Medical Center is committed to bringing our patients the latest clinical discoveries as well as opportunities to participate in groundbreaking clinical trials in a safe and compassionate way. We partner with the University of Medicine and Dentistry of New Jersey — New Jersey Medical School in Newark, New Jersey, Kessler Institute for Rehabilitation, and Albert Einstein College of Medicine in New York City, to give our MS patients access to today's most promising therapies that reduce the chances for relapse or further progression.